Caixin
Aug 11, 2020 02:47 PM
BUSINESS & TECH

Japan, U.K. to Launch $20 Billion Global Vaccine Alliance, Countering U.S., China

A pharmaceutical biochemist neutralizes and separates genetic material from a SARS-CoV-2 test at a laboratory at the Autonomous University of San Luis Potosi (UASLP) Research Center in Health Sciences and Biomedicine in San Luis Potosi, Mexico, on July 24. Photo: Bloomberg
A pharmaceutical biochemist neutralizes and separates genetic material from a SARS-CoV-2 test at a laboratory at the Autonomous University of San Luis Potosi (UASLP) Research Center in Health Sciences and Biomedicine in San Luis Potosi, Mexico, on July 24. Photo: Bloomberg

(Nikkei Asian Review) — Japan, the U.K. and more than 70 other countries plan to form an alliance this fall to jointly procure 2 billion doses of coronavirus vaccines by 2021, looking to gain financial leverage in talks with pharmaceutical companies.

The partnership, initially pitched around June by Japan, the U.K., Germany, France and the EU, aims to pool up to $20 billion. The alliance, named Covax, will pay vaccine makers in advance and procure doses for member countries. Supplies for individual nations will be capped at 20% of the population.

The U.S. and China each have deep enough pockets to negotiate vaccine deals independently, putting others at a disadvantage. Japan intends to use the partnership to level the playing field in talks with vaccine developers, especially when dealing with a Chinese or American manufacturer.

About 75 nations have expressed interest, including Canada, South Korea and Argentina. Membership requires an upfront investment, and the deadline for joining the group is set for the end of August. But the EU has been reluctant, with Germany and France noncommittal at this time, a source close to the Japanese government said.

Gavi, a public-private organization that supports global immunization efforts, will run Covax. Participating nations and groups are expected to contribute over $20 billion combined toward the cause.

The goal is to start supplying vaccines in the first half of 2021. Funds donated to Gavi also will be used to procure doses for distribution in developing countries.

China and the U.S. are unlikely to join the effort, a Japanese government insider said. The U.S., which has the most cases of Covid-19, is competing with Europe to secure vaccine supplies from European makers. Beijing plans to produce the vaccines at home for local consumption.

Tokyo is also busy discussing separate vaccine deals with overseas suppliers. Japan has reached a basic agreement with Pfizer to procure 120 million doses by June 2021, enough to inoculate 60 million people. Japan and AstraZeneca reached another preliminary deal announced Friday to supply 120 million doses.

Securing a stockpile of vaccines is considered crucial for the Tokyo Olympics, now postponed to next summer. Without vaccinations on a global scale, the event will face serious complications.

This article originally appeared in the Nikkei Asian Review

Download our app to receive breaking news alerts and read the news on the go.

Contact editor Yang Ge (geyang@caixin.com)

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code